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of affecting human life.[1] Its pathogen was detected by Robert 
Koch more than 100 years ago, and the disease is still regarded 
as an important underlying cause for most of the mortalities and 
morbidities among other chronic infectious diseases.[1] Up to 
2010, 8.8 million new cases of TB and 1.4 million TB-related 
deaths have been reported worldwide;[2] approximately 95% 
of TB cases and 98% of TB-induced mortality occur in 
underdeveloped and developing countries.[3] Despite strong 
control for TB and routine implementation of directly observed 
treatment, short-course (DOTS) program, 14,000 new cases 
have been reported annually in Iran. Iran is categorized as a 
developing country in West Asia.[4] The average prevalence 
of TB in Iran was estimated at 33/100,000 in 2012 by the 
World Health Organization (WHO).[5] Reports from different 
countries indicate that the rate of recent transmission in 
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Abstract
Background: Identifying Mycobacterium tuberculosis (MTB) transmission type is a key step 
in the control of this disease. Aim: This study aimed to determine the path and transmission 
type of MTB and the insertion sequence IS6110 band number and verify their relationship 
to demographic and clinical risk factors. Subjects and Methods: In this cross‑sectional study, 
64 MTB patients from three border provinces of Iran were selected after full clinical history 
and physical evaluation design. The drug susceptibility testing was carried out using the 
standard proportion technique on sputum samples. Isolates tested with restriction fragment 
length polymorphism technique used IS6110. Results: Recent transmission of disease was 
33/50 (66%) based on clustering rate. The IS6110 band number had a significant relationship 
with drug resistance detected in proportion method tested by univariate linear regression (P < 
0.01). Furthermore, the IS6110 band number had association with Bacillus Calmette–Guérin 
vaccination history (P = 0.02), sex (P < 0.01), and purified protein derivative (PPD) reaction 
size (P < 0.01) tested by multiple analysis. The risk of recent transmission inferred from the 
clustering rate was significantly higher in patients from Western provinces compared to those 
from the North‑West province (P = 0.048). However, age (P = 0.39), gender (P = 0.16), 
vaccination history (P = 0.57), drug susceptibility, and PPD (P = 0.6) were independent 
of clustering. The largest cluster of up to six subjects was found in the Western provinces. 
Conclusion: Recent MTB transmission was much more common in the West compared to the 
North‑West of Iran. Large MTB clusters with strong epidemiological links may be reflective 
of a disease outbreak. Correlation noted between the IS6110 band number and vaccination 
history; PPD size and female gender necessitates further studies.
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low-income countries is more than in developed countries. 
Furthermore, it has to be mentioned that the estimation of 
recent transmission and recurrence rates of TB have a particular 
application in the TB control program.
An important factor in the complexity of TB control is 
the disease’s increasing drug resistance.[6] The prevalence 
of drug-resistant TB in Iran is 5% among newly affected 
patients and 48% among patients with a recurrence of their 
previous infection.[4] Although, Iran is ranked moderate in 
terms of the prevalence of TB and TB (multidrug-resistant 
tuberculosis [MDR]),[5] being bordered by countries with a 
high prevalence of TB, including Iraq to the West and the 
high prevalence of Mycobacterium tuberculosis (MTB), 
and MDR-TB in the Republic of Azerbaijan to the 
North-West,[4] makes it necessary to track the transmission 
path of TB and control its prevalence. It can also be said 
that	the	identification	of	disease	transmission	type,	including	
those endogenous (recurrence of a previous infection) or 
exogenous (new transmission of the disease) in nature, as well 
as its severity (response to treatment) are the key factors in 
the control of TB. At present, several genotyping techniques 
have been developed which provide invaluable information 
including the determination of the strain, infection 
transmission routing, and transmission type (old or new). 
Among multiple genotyping techniques, IS6110-restriction 
fragment length polymorphism (RFLP) is widely used as 
a standard method across laboratories worldwide, and its 
advantage is demonstrated in a recent review by Jagielski 
et al.[7] Our study aimed to determine the transmission type 
of MTB in patients with a positive pulmonary smear in 
three frontier provinces of Iran and analyze the relationship 
of demographic and clinical characteristics with the 
transmission type of MTB.
Subjects and Methods
In this cross-sectional study, from 2012 to 2014, 64 patients 
with positive pulmonary smears from East Azerbaijan 
(n = 30), Kurdistan (n = 17), and Kermanshah (n = 17) 
provinces located in the North-West and West of Iran were 
investigated. This study was approved by the Medical Ethics 
Committees of Tabriz Medical University; moreover, patients 
were selected randomly to avoid selection bias and asked for 
written informed consent before interviews. The inclusion 
criteria were: At least two positive pulmonary smears for 
acid-fast bacilli, or one positive pulmonary smear along with 
radiographic abnormalities consistent with active pulmonary 
TB, or one positive smear and one positive MTB culture.[8] 
MTB	was	identified	using	para‑nitrobenzoic	acid.
DNA extraction
DNA was extracted from clinical isolates grown on the 
Löwenstein–Jensen (LJ) medium as described in a study by 
van Soolingen et al.[9]
Drug susceptibility testing
Drug susceptibility testing was carried out using the LJ medium 
according to the proportion method recommended by the WHO 
and the International Union Against TB and Lung Disease 
using the following materials:[9] Isoniazid (INH): 0.2 mg/L, 
rifampicin (RMP): 40 mg/L, ethambutol (EMB): 2 mg/L, and 
streptomycin (STM): 4 mg/L.
IS6110‑RFLP
To implement the IS6110‑RFLP, the PVUII-digested DNA 
was separated on 1% agarose gels and capillary-blotted onto 
a nylon membrane. A 245-base pair internal polymerase chain 
reaction (PCR) fragment of IS6110	was	 amplified	by	PCR	
and used as a probe. After labeling, the hybridization of the 
DNA was performed at 42°c for 24 h following manufacturer 
(ECL System, GE Healthcare UK Limited, Amersham 
Place Little Chalfont, Buckinghamshire, UK). The total of 
PVUII-digested DNA of the MTB reference strain H37RV was 
used as the control in Southern blot experiments.
Computer analysis
The IS6110 fingerprinting pattern of MTB strains were 
analyzed using Gel Compare II (Windows 7, version 6.6, 
Applied	Math,	Kortrijk,	Belgium).	At	first,	the	autoradiograms	
were scanned with an optical resolution of 190 dpi, then the 
position of IS6110 was normalized by an internal marker, and its 
accuracy	was	verified	using	IS6110 banding pattern in H37RV 
strains. The similarity of the matrix was estimated using dice 
band‑based	similarity	coefficient	at	a	2%	tolerance‑interval,	
1% optimization, and a 10–95% active zone. Similarity 
was considered above 70% when determining clustering. 
Dendrograms were designed by the hierarchic un-weighted 
pair clustering group method analysis algorithm.
Statistical tests
In a pilot study, the validity of the questionnaire was evaluated 
as	 confirmed	 by	 expert	 professors,	 and	 its	 reliability	was	
assessed using the statistical reliability test (Cronbach’s 
alpha = 0.92). A univariate logistic regression test was used 
to compare geographic, clinical, and demographic variables 
in the clusters (recent transmission) and unique (recurring 
transmission) groups. Univariate and multiple linear regression 
tests were used for analysis of the mean number of strains’ 
bands per geographical regions, drug resistance, vaccination 
history,	 purified	protein	 derivative	 (PPD)	diameter,	 gender,	
age, immigration history, and family history of TB using 
Statistical Package for the Social Sciences (SPSS-18) software 
(IBM SPSS, Chicago, Illinois, USA).
Results
There were 31 men, 31/64 (48.4%) and 33/64 (51.6%) 
women involved in our study. The mean age of subjects was 
54.4 (23.62) years (range: 15–83 years). They were HIV 
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negative (ELISA test), and underwent DOTS system during 
treatment.
The prevalence of any drug resistance and MDR was 
9/64 (14.1%) and 2/64 (3.1%) among TB patients, respectively. 
And the frequency of resistance to RMP was 3/64 (4.7%), 
to INH was 3/64 (4.7%), to STM was 5/64 (7.8%), and to 
EMB was 2/64 (3.1%). The average number of bands was 
9.2 (standard deviation [SD] =3.2) and the minimum and 
maximum number of isolate bands were 3 and 16, respectively. 
In this study, 14/64 (21.88%) isolates had less than seven 
bands, which were excluded from similarity analysis. After the 
exclusion of bands less than seven, 17/50 (34%) isolates were 
unique and 33/50 (66%) isolates were clustered. Composition 
of clusters of isolates were as follows, seven clusters with two 
isolates, tree clusters with three isolates, one cluster with four 
isolates, and one cluster with six isolates [Figure 1].
In a comparison of classical and molecular epidemiology 
results,	significant	geographical	and	gender	matching	existed	
within different clusters [Table 1]. Typically, an increased 
number of isolates in each cluster decreases the probability 
of matching between classic and molecular data. Meanwhile, 
the largest cluster of six members had a 100% geographical 
connection; all six members were from the Western 
provinces [Table 1]. In one of the dual clusters, no classical 
connection existed between them and given that these two 
samples were always together during the experiment, there 
was	a	possibly	of	cross‑contamination,	although	no	definite	
comment can be made in this case.
In terms of formed clusters, 9/33 (27.27%) of East Azerbaijan 
strains, 12/33 (36.36%) of Kermanshah strains, and 
12/33 (36.36%) of Kurdistan strains were involved in clustering. 
Accordingly, isolates from Kurdistan and Kermanshah were 
more involved in the creation of large population clusters.
In	terms	of	drug	resistance,	there	was	a	significant	relationship	
between any drug resistance and the band number of the strains 
in univariate linear regression analysis (β =2.5, P = 0.04).
The average number of strains’ bands in isolates from 
the North-West and West geographical regions differed 
significantly	 from	 each	 other	 so	 that	 the	mean	 number	 of	
bands was 7.2 (SD = 2.5) in East Azerbaijan strains, and 
10.8 (SD = 2.8) in Kurdistan and Kermanshah (P < 0.001). 
Interestingly,	there	was	a	statistically	significant	relationship	
between the band number of strains and vaccination history, 
PPD diameter, and gender in multiple linear regression. 
Therefore, in female patients without vaccination history, 
the number of bands in TB strains were more than in patients 
with vaccination history and males (P < 0.01 and P < 0.001, 
respectively) and negative correlation existed between PPD 
diameter and the number of bands (P < 0.01) [Table 2].
Comparative analysis of the North-West and West provinces 
based on the odds of clustering showed that isolates from 
Western	provinces	had	a	significantly	(6	times)	higher	chance	
to form clusters than those from East Azerbaijan (odds 
ratio	 [OR]	=6.0,	 confidence	 interval	 [CI]	 0.95%:	1.4–24.7, 
P = 0.013).
No	significant	statistical	relationship	was	found	when	comparing	
gender, age, vaccination history, PPD, and drug susceptibility in 
unique and clustered groups. Sex (female): OR = 3.3, CI 95%, 
0.6–18.0, P = 0.16; age (year): β	=	−0.019,	SE	 (β) =0.023, 
P = 0.39; vaccination history (yes): OR = 0.57, CI 95%, 0.055–5.8, 
P = 0.63; PPD (mm): β =0.27, SE (β) =0.56, P = 0.63 any drug 
resistance (yes): OR = 1.9, CI 95%, 0.02–7.7, P = 0.60.
Discussion
The participants of the present study were native to 
East Azerbaijan (North-West of Iran), Kurdistan, and 
Table 1: Classical epidemiologic information connection in Mycobacterium tuberculosis patients of Iran
Number cluster 
(number isolates in cluster)
Epidemiological link; n (%)
Geographical Gender Aging Vaccination
Yes No Yes No Yes No Yes No
7 (n=2) 5 (71.42) 2 (28.6) 4 (57.1) 3 (42.9) 1 (14.2) 6 (85.8) 2 (28.57) 5 (71.43)
3 (n=3) 2 (66.7) 1 (33.3) 1 (33.3) 2 (66.7) 1 (33.3) 2 (66.7) 1 (33.3) 2 (66.7)
1 (n=4) 0 (0.0) 1 (100.0) 0 (0.0) 1 (100.0) 0 (0.0) 1 (100.0) 0 (0.0) 1 (100.0)
1 (n=6) 1 (100.0) 0 (0.0) 1 (100.0) 0 (0.0) 0 (0.0) 1 (100.0) 1 (100.0) 0 (0.0)
Figure 1: IS6110 DNA fingerprint patterns of the 64 Mycobacterium 
tuberculosis strains and the corresponding dendrogram banding 
patterns are ordered by similarity. The position of each IS6110 band 
is normalized so that banding patterns of all strains are mutually 
comparable. Scale depicts similarity of patterns calculated as described 
in materials and methods
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Kermanshah Provinces (West of Iran). Among 64 strains 
in different patients, the mean number of bands of IS6110 
was 9.1 (SD = 3.2). In the present study, the frequency of 
strains with less than seven bands was 14 (21.88% of the 
isolates). The relative frequency of low-bands strains in 
various regions was highly diverse. For example, in Abbadi’s 
study in Egypt, none of the models were low-copy (less 
than	five	bands),[10] whereas in the study by Siddiqi in India, 
approximately	42%	of	isolates	had	less	than	five	bands.[11] 
There is also no consistency in the relative frequency of 
an IS6110 copy-number in different regions of Iran[9,12-14]; 
for example, the percentage of isolates with less than six 
copies was 3.2% in Fars Province (South of Iran),[9] 38% in 
Khorasan Province (East of Iran),[13] and 22.75% in Markazi 
Province (Central Iran).[14] It seems that the number of bands 
is	 influenced	 by	 different	 geographic	 regions.	However,	
the	mean	number	of	bands	varied	significantly	in	different	
geographical regions (P < 0.001), but in a closer examination 
and modeling based on multiple analysis, this association was 
not maintained. It is possible that the unique characteristics 
of each region may affect the variation in band number and in 
this regard, the region may play a role as a mediating variable.
In conformity with Green’s study in South Africa,[15] a 
significant	 relationship	was	 found	between	drug	 resistance	
and band number in univariate linear regression, but this 
association was not maintained in multiple analyses. In our 
study, patients with no history of vaccination were at higher 
odds of infection by MTB isolates with a greater number of 
IS6110 bands. Based on some studies, vaccination can prevent 
the development of more severe forms of the disease in 
children.[16] In addition, vaccination strongly protects against 
extra-pulmonary TB.[17] According to the study by Lei in 
China, the odds of infection with resistant TB in individuals 
with a vaccination history was low.[18] Given the possible 
relationship between strain type and drug resistance on one 
hand[19] and relationship of the strain type and the number 
of IS6110 bands in various strains[20] on the other, it seems 
that there is a relationship between vaccination history and 
the number of bands. This result may indicate the crucial 
assumption that vaccination creates more immunity against 
MTB strains with low band number, which necessitates 
further	research	in	this	area.	Another	finding	about	different	
band numbers of MTB isolates was PPD diameter so that 
with increased PPD diameter, the likelihood of a higher 
number of bands in isolates was low. Based on the results 
of a study by Shahemabadi et al. in 2007, obvious changes 
occur in immunological responses, hence PPD in patients 
with MDR-TB.[21] However, no study is available about strain 
type or isolates band number and immunological response in 
the patients.
Another important result is that women were more likely to 
have high-band isolates than men. Studies show that genetic 
characteristics highly affect the manifestation, severity, and 
drug resistance of MTB.[22] Therefore, the IS6110 band number 
of strains may also be related to gender. However, in general, 
the mechanism(s) by which the IS6110 copy number affects 
the characteristic of strains is/are unclear, and further studies 
need to be made to address this issue.
In the present study, the relative frequency of clustering groups 
was 66%. This is higher than the frequency reported in another 
study in Iran in which the clustering rate was 43%.[23] In a study 
conducted in Arkansas, the clustering percentage was 52%.[24] 
Abbadi reported the clustering rate as 18% in Egypt[10] and 
Borges reported 29% in Brazil.[25]
In	the	present	study,	the	geographic	region	had	a	significant	
relationship with clustering and hence the risk of new 
transmission. Because of this, the majority of patients in 
the Western provinces (Kurdistan and Kermanshah) were 
infected due to the recent transmission of the disease. 
The largest cluster of up to six subjects was found in the 
Western provinces (which can be a serious warning of a 
potential	outbreak	in	the	specific	area).	This	outbreak	may	
originate from Iraqi states adjacent to these provinces. To 
consolidate this hypothesis, further investigation is required 
to determine and compare the common strains with those in 
Iraq and the Azerbaijan Republic. In the present study, no 
statistically	significant	relationship	was	found	between	age	
and gender with clustering in TB-related isolates. Although 
a positive relationship was achieved between males and 
clustering in a study in France,[26] a number of studies 
have reported age and gender independent of clustering.
[27,28] In our study, the epidemiological link based on area, 
vaccination history, and gender were obtained 59.53, 
40.47, and 44.4%, respectively, for patients with the recent 
transmission. In a study by Borger, the epidemiological link 
based on residential proximity and the family reaction was 
37.5%,[25] whereas it was 30.2% in Hong Kong.[28] Due to a 
strong correlation between band number of IS6110 and no 
vaccination history, PPD diameter, and female gender, it is 
Table 2: Multiple analyzing of age, sex, vaccination history, 
PPD, drug resistance, area, migration history factors on 





Vaccination history (no: 1, yes: 2) −2.65 1.05 0.020
PPD (mm) −0.27 0.08 0.003
Sex (male: 1, female: 2) 3.15 0.735 0.00
Migration history (no: 1, yes: 2) 1.298 1.32 0.53
Age (year) 0.031 0.023 0.193
History of TB in family (no: 0, yes: 1) 1.52 1.24 0.233
Drug resistance (no: 0, yes: 1) 0.32 1.37 0.080
Province (Kurdistan and 
Kermanshah: 0, East Azerbaijan: 1)
−2.55 1.45 0.094
SE: Standard error, PPD: Purified protein derivative, TB: Tuberculosis
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necessary to conduct further studies to determine the causal 
relationship.
In this study, recent transmission of the disease was much 
more common in the West compared to North-West of Iran. 
Large MTB clusters with strong epidemiological links may be 
reflective	of	a	disease	outbreak.	Correlation	noted	between	the	
IS6110 band number and vaccination history, PPD size, and 
female gender necessitates further studies.
Acknowledgment
This research was a section of Ph.D. Thesis. We wish to thank 
Mrs. Lesley Carson, who helpfully edited the article.
References
1. Daniel TM. The history of tuberculosis. Respir Med 
2006;100:1862‑70.
2. WHO. Multidrug‑resistant Tuberculosis (MDR‑TB). Geneva, 
Switzerland: The World Health Organization. Available 
from: http://www.who.int/tb/challenges/mdr/en/. 
[Last updated on 2015 Apr 12; Last cited on 2012 Oct 17].
3. Gebeyehu E, Azage M, Abeje G. Factors associated with 
patient’s delay in tuberculosis treatment in Bahir Dar 
City administration, Northwest Ethiopia. Biomed Res Int 
2014;2014:701429.
4. WHO. Global Tuberculosis Report. Geneva, Switzerland: 
The World Health Organization; 2014. Available from: 
http://www.who.int/tb/publications/global_report/en/. 
[Last updated on 2015 Apr 12; Last cited on 2014 Nov 21].
5. Soleimanpour S, Hamedi Asl D, Tadayon K, Farazi AA, 
Keshavarz R, Soleymani K, et al. Extensive genetic diversity 
among clinical isolates of Mycobacterium tuberculosis in central 
province of Iran. Tuberc Res Treat 2014;2014:195287.
6. Sahebi L,  Ansarin K, Maryam S, Monfaredan A, 
Sabbgh Jadid H. The factors associated with tuberculosis 
recurrence in the Northwest and West of Iran. Malays J Med 
Sci 2014;21:27‑35.
7. Jagielski T, van Ingen J, Rastogi N, Dziadek J, Mazur PK, 
Bielecki J. Current methods in the molecular typing of 
Mycobacterium tuberculosis and other mycobacteria. Biomed 
Res Int 2014;2014:645802.
8. Biadglegne F, Rodloff AC, Sack U. A first insight into high 
prevalence of undiagnosed smear‑negative pulmonary 
tuberculosis in Northern Ethiopian prisons: Implications 
for greater investment and quality control. PLoS One 
2014;9:e106869.
9. van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, 
Portaels F, et al. Predominance of a single genotype of 
Mycobacterium tuberculosis in countries of east Asia. J Clin 
Microbiol 1995;33:3234‑8.
10. Abbadi S, El Hadidy G, Gomaa N, Cooksey R. Strain 
differentiation of Mycobacterium tuberculosis complex isolated 
from sputum of pulmonary tuberculosis patients. Int J Infect 
Dis 2009;13:236‑42.
11. Siddiqi N, Shamim M, Amin A, Chauhan DS, Das R, 
Srivastava K, et al. Typing of drug resistant isolates of 
Mycobacterium tuberculosis from India using the IS6110 
element reveals substantive polymorphism. Infect Genet 
Evol 2001;1:109‑16.
12. Doroudchi M, Kremer K, Basiri EA, Kadivar MR, 
Van Soolingen D, Ghaderi AA. IS6110‑RFLP and spoligotyping 
of Mycobacterium tuberculosis isolates in Iran. Scand J Infect 
Dis 2000;32:663‑8.
13. Farnia P, Masjedi MR, Mirsaeidi M, Mohammadi F, 
Jallaledin‑Ghanavi, Vincent V, et al. Prevalence of Haarlem I 
and Beijing types of Mycobacterium tuberculosis strains in 
Iranian and Afghan MDR‑TB patients. J Infect 2006;53:331‑6.
14. Rafiee B, Mosavari N, Farazi A, Nazari R, Keshavarz R, 
Tadayon K. DNA fingerprinting of Mycobacterium tuberculosis 
isolates of pulmonary tuberculosis patients in Markazi 
province by PGRS‑RFLP method. Arak Univ Med Sci J 
2012;15:35‑44.
15. Green E, Obi LC, Okoh AI, Nchabeleng M, de Villiers BE, 
Letsoalo T, et al. IS6110 restriction fragment length 
polymorphism typing of drug‑resistant Mycobacterium 
tuberculosis strains from northeast South Africa. J Health Popul 
Nutr 2013;31:1‑10.
16. WHO. Tuberculosis (TB). Frequently Asked Questions‑XDR‑TB. 
Geneva, Switzerland: The World Health Organization. 
Available from: http://www.who.int/tb/challenges/xdr/
faqs/en/. [Last updated on 2015 2015April 10Last cited on 
2012 Jan 26].
17. WHO. Tuberculosis Vaccines. Geneva, Switzerland: The 
World Health Organization. Available from: http://www.
who.int/tb/vaccinesfaqs/en/. [Last updated 2015 Apr 10; 
Last cited on 2014 Oct 14].
18. Lei JP, Xiong GL, Hu QF, Li Y, Zong PL, Tu SH, et al. 
Immunotherapeutic efficacy of BCG vaccine in pulmonary 
tuberculosis and its preventive effect on multidrug‑resistant 
tuberculosis. Zhonghua Yu Fang Yi Xue Za Zhi 2008;42:86‑9.
19. Liu BB, Lu LP, Lü B, Wan KL, Yan Y. Meta analysis on the 
correlation between Mycobacterium tuberculosis Beijing family 
strains and drug resistance. Zhonghua Yu Fang Yi Xue Za Zhi 
2012;46:158‑64.
20. Kremer K, Glynn JR, Lillebaek T, Niemann S, Kurepina NE, 
Kreiswirth BN, et al. Definition of the Beijing/W lineage of 
Mycobacterium tuberculosis on the basis of genetic markers. 
J Clin Microbiol 2004;42:4040‑9.
21. Shahemabadi AS, Hosseini AZ, Shaghsempour S, Masjedi MR, 
Rayani M, Pouramiri M. Evaluation of T cell immune 
responses in multi‑drug‑resistant tuberculosis (MDR‑TB) 
patients to Mycobacterium tuberculosis total lipid antigens. Clin 
Exp Immunol 2007;149:285‑94.
22. Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug 
resistant tuberculosis in Europe: A systematic review. Thorax 
2006;61:158‑63.
23. Farnia P, Mohammadi F, Masjedi MR, Varnerot A, Zarifi AZ, 
Tabatabee J, et al. Evaluation of tuberculosis transmission 
in Tehran: Using RFLP and spoligotyping methods. J Infect 
2004;49:94‑101.
24. Cave MD, Yang ZH, Stefanova R, Fomukong N, Ijaz K, 
Bates J, et al. Epidemiologic import of tuberculosis cases 
whose isolates have similar but not identical IS6110 restriction 
fragment length polymorphism patterns. J Clin Microbiol 
2005;43:1228‑33.
25. Borges M, Cafrune PI, Possuelo LG, Valim AR, Ribeiro MO, 
Rossetti ML. Molecular analysis of Mycobacterium tuberculosis 
strains from an outpatient clinic in Porto Alegre, (RS). J Bras 
Pneumol 2004;4:448‑53.
Sahebi, et al.: Molecular epidemiology of Mycobacterium tuberculosis
Annals of Medical and Health Sciences Research | Sep-Oct 2015 | Vol 5 | Issue 5 | 339
26. Gutiérrez MC, Vincent V, Aubert D, Bizet J, Gaillot O, 
Lebrun L, et al. Molecular fingerprinting of Mycobacterium 
tuberculosis and risk factors for tuberculosis transmission in Paris, 
France, and surrounding area. J Clin Microbiol 1998;36:486‑92.
27. McConkey SJ, Williams M, Weiss D, Adams H, Cave MD, 
Yang Z, et al. Prospective use of molecular typing of 
Mycobacterium tuberculosis by use of restriction fragment‑length 
polymorphism in a public tuberculosis‑control program. Clin 
Infect Dis 2002;34:612‑9.
How to cite this article: ???? 
 
Source of Support: Nil. Conflict of Interest: None declared.
28. Chan‑Yeung M, Tam CM, Wong H, Leung CC, Wang J, 
Yew WW, et al. Molecular and conventional epidemiology of 
tuberculosis in Hong Kong: A population‑based prospective 
study. J Clin Microbiol 2003;41:2706‑8.
Author Help: Reference checking facility
The manuscript system (www.journalonweb.com) allows the authors to check and verify the accuracy and style of references. The tool checks 
the references with PubMed as per a predefined style. Authors are encouraged to use this facility, before submitting articles to the journal.
•	 The style as well as bibliographic elements should be 100% accurate, to help get the references verified from the system. Even a 
single spelling error or addition of issue number/month of publication will lead to an error when verifying the reference. 
•	 Example of a correct style
 Sheahan P, O’leary G, Lee G, Fitzgibbon J. Cystic cervical metastases: Incidence and diagnosis using fine needle aspiration biopsy. 
Otolaryngol Head Neck Surg 2002;127:294-8. 
•	 Only the references from journals indexed in PubMed will be checked. 
•	 Enter each reference in new line, without a serial number.
•	 Add up to a maximum of 15 references at a time.
•	 If the reference is correct for its bibliographic elements and punctuations, it will be shown as CORRECT and a link to the correct 
article in PubMed will be given.
•	 If any of the bibliographic elements are missing, incorrect or extra (such as issue number), it will be shown as INCORRECT and link to 
possible articles in PubMed will be given. 
